|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Damber JE: Endocrine therapy for prostate
cancer. Acta Oncol. 44:605–609. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li LC, Okino ST, Zhao H, Pookot D, Place
RF, Urakami S, Enokida H and Dahiya R: Small dsRNAs induce
transcriptional activation in human cells. Proc Natl Acad Sci USA.
103:17337–17342. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Place RF, Li LC, Pookot D, Noonan EJ and
Dahiya R: MicroRNA-373 induces expression of genes with
complementary promoter sequences. Proc Natl Acad Sci USA.
105:1608–1613. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Catto JW, Alcaraz A, Bjartell AS, De Vere
White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L,
Schlomm T, et al: MicroRNA in prostate, bladder, and kidney cancer:
A systematic review. Eur Urol. 59:671–681. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fendler A, Stephan C, Yousef GM and Jung
K: MicroRNAs as regulators of signal transduction in urological
tumors. Clin Chem. 57:954–968. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fabris L, Ceder Y, Chinnaiyan AM, Jenster
GW, Sorensen KD, Tomlins S, Visakorpi T and Calin GA: The potential
of microRNAs as prostate cancer biomarkers. Eur Urol. 70:312–322.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Warfel NA and El-Deiry WS: p21WAF1 and
tumourigenesis: 20 years after. Curr Opin Oncol. 25:52–58. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eastham JA, Hall SJ, Sehgal I, Wang J,
Timme TL, Yang G, Connell-Crowley L, Elledge SJ, Zhang WW, Harper
JW, et al: In vivo gene therapy with p53 or p21 adenovirus for
prostate cancer. Cancer Res. 55:5151–5155. 1995.PubMed/NCBI
|
|
11
|
Huang V, Place RF, Portnoy V, Wang J, Qi
Z, Jia Z, Yu A, Shuman M, Yu J and Li LC: Upregulation of Cyclin B1
by miRNA and its implications in cancer. Nucleic Acids Res.
40:1695–1707. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiao H, Zeng J, Li H, Chen K, Yu G, Hu J,
Tang K, Zhou H, Huang Q, Li A, et al: MiR-1 downregulation
correlates with poor survival in clear cell renal cell carcinoma
where it interferes with cell cycle regulation and metastasis.
Oncotarget. 6:13201–13215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang C, Ge Q, Chen Z, Hu J, Li F, Song X,
Xu H and Ye Z: A new double stranded RNA suppresses bladder cancer
development by upregulating p21 (Waf1/CIP1) expression. Biomed Res
Int. 2015:3047532015.PubMed/NCBI
|
|
14
|
Wang C, Chen Z, Ge Q, Hu J, Li F, Hu J, Xu
H, Ye Z and Li LC: Up-regulation of p21(WAF1/CIP1) by miRNAs and
its implications in bladder cancer cells. FEBS Lett. 588:4654–4664.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sperka T, Wang J and Rudolph KL: DNA
damage checkpoints in stem cells, ageing and cancer. Nat Rev Mol
Cell Biol. 13:579–590. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bloom J and Cross FR: Multiple levels of
cyclin specificity in cell-cycle control. Nat Rev Mol Cell Biol.
8:149–160. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hallstrom TC and Nevins JR: Balancing the
decision of cell proliferation and cell fate. Cell Cycle.
8:532–535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Denicourt C and Dowdy SF: Cip/Kip
proteins: More than just CDKs inhibitors. Genes Dev. 18:851–855.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Place RF, Wang J, Noonan EJ, Meyers R,
Manoharan M, Charisse K, Duncan R, Huang V, Wang X and Li LC:
Formulation of small activating RNA into lipidoid nanoparticles
inhibits xenograft prostate tumor growth by inducing p21
expression. Mol Ther Nucleic Acids. 1:e152012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng L, Wang L, Gan J and Zhang H: RNA
activation: Promise as a new weapon against cancer. Cancer Lett.
355:18–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Portnoy V, Lin SH, Li KH, Burlingame A, Hu
ZH, Li H and Li LC: saRNA-guided Ago2 targets the RITA complex to
promoters to stimulate transcription. Cell Res. 26:320–335. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Portnoy V, Huang V, Place RF and Li LC:
Small RNA and transcriptional upregulation. Wiley Interdiscip Rev
RNA. 2:748–760. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stark A, Brennecke J, Russell RB and Cohen
SM: Identification of Drosophila MicroRNA targets. PLoS Biol.
1:E602003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Younger ST, Pertsemlidis A and Corey DR:
Predicting potential miRNA target sites within gene promoters.
Bioorg Med Chem Lett. 19:3791–3794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Needleman SB and Wunsch CD: A general
method applicable to the search for similarities in the amino acid
sequence of two proteins. J Mol Biol. 48:443–453. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mitchell T and Neal DE: The genomic
evolution of human prostate cancer. Br J Cancer. 113:193–198. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Barbieri CE and Tomlins SA: The prostate
cancer genome: Perspectives and potential. Urol Oncol.
32:53.e15-222014. View Article : Google Scholar : PubMed/NCBI
|
